These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9399621)

  • 1. Warfarin resistance associated with intravenous lipid administration: discussion of propofol and review of the literature.
    MacLaren R; Wachsman BA; Swift DK; Kuhl DA
    Pharmacotherapy; 1997; 17(6):1331-7. PubMed ID: 9399621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous warfarin as an alternative for anticoagulation.
    Gellatly RM
    Pharmacotherapy; 2007 Jun; 27(6):933-5. PubMed ID: 17542775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition.
    Dickerson RN; Garmon WM; Kuhl DA; Minard G; Brown RO
    Pharmacotherapy; 2008 Mar; 28(3):308-13. PubMed ID: 18294110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Perioperative management for hemicolectomy using propofol infusion in an elderly patient with a mechanical heart valve prosthesis].
    Tabuchi Y
    Masui; 2000 Mar; 49(3):269-73. PubMed ID: 10752319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term sedation with propofol 60 mg ml(-1) vs. propofol 10 mg(-1) ml in critically ill, mechanically ventilated patients.
    Knibbe CA; Naber H; Aarts LP; Kuks PF; Danhof M
    Acta Anaesthesiol Scand; 2004 Mar; 48(3):302-7. PubMed ID: 14982562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin, short bowel syndrome, and intravenous lipids.
    Lutomski DM
    Pharmacotherapy; 1998; 18(6):1375-6. PubMed ID: 9855342
    [No Abstract]   [Full Text] [Related]  

  • 7. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin resistance associated with intravenous lipid administration.
    Lutomski DM; Palascak JE; Bower RH
    JPEN J Parenter Enteral Nutr; 1987; 11(3):316-8. PubMed ID: 3110450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebral hemorrhage associated with use of an imported medication.
    Haidar WN; Hoel RW; Takahashi PY
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):197-200. PubMed ID: 15561652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between gemfibrozil and warfarin: case report and review of the literature.
    Dixon DL; Williams VG
    Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed elevation of international normalized ratio with concurrent clarithromycin and warfarin therapy.
    Oberg KC
    Pharmacotherapy; 1998; 18(2):386-91. PubMed ID: 9545160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of methimazole on warfarin anticoagulation in a case of Graves' disease.
    Akin F; Yaylali GF; Bastemir M; Yapar B
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):89-91. PubMed ID: 18180622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fish oil interaction with warfarin.
    Buckley MS; Goff AD; Knapp WE
    Ann Pharmacother; 2004 Jan; 38(1):50-2. PubMed ID: 14742793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin resistance associated with parenteral nutrition.
    Cheung LK; Agi R; Hyman DJ
    Am J Med Sci; 2012 Mar; 343(3):255-8. PubMed ID: 22143126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antithrombotic effect of warfarin associated with low-dose alcohol consumption.
    Havrda DE; Mai T; Chonlahan J
    Pharmacotherapy; 2005 Feb; 25(2):303-7. PubMed ID: 15767245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Graves' disease and methimazole on warfarin anticoagulation.
    Busenbark LA; Cushnie SA
    Ann Pharmacother; 2006 Jun; 40(6):1200-3. PubMed ID: 16735660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fat deposits in the placenta following maternal total parenteral nutrition with intravenous lipid emulsion.
    Jasnosz KM; Pickeral JJ; Graner S
    Arch Pathol Lab Med; 1995 Jun; 119(6):555-7. PubMed ID: 7605175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.